Mendra
Develops and commercializes rare disease therapies using AI
$82MSeries A
Role not disclosed8
8VC
Activity from announced rounds
Activity in this selectionJan 31, 2026 · Jan 1, 2026
8VC invests in and builds technology companies in life sciences, healthcare, manufacturing, enterprise software, logistics and defence.
Its Build programme creates companies when the team identifies an opportunity without an existing business to back. This adds a company-formation route to its conventional investment activity, relevant to entrepreneurs developing a technology platform from the outset.
The firm also runs engineering and Bio-IT fellowships connecting emerging technical talent with its companies. These programmes reflect its emphasis on recruiting builders for sectors where software, scientific expertise and physical operations intersect.
Sources
- Rounds participated in
- 5
- Confirmed lead rounds
- — 5 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $271.3M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionJetson
Provides all-electric heat pump systems for residential electrification
$50MSeries A
Role not disclosedTerra Industries
Builds autonomous defense systems and infrastructure for countries in the Global South
$11.8MUndisclosed
Role not disclosedFlywheel
Medical imaging data management and analysis platform
$27.5MUndisclosed
Role not disclosedCambium
Cambium develops advanced materials for defense, aerospace and other high-performance applications using AI.
$100MSeries B
Role not disclosed